Judge rejects request to sideline SJSU volleyball player
MIAMI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. NSPR , developer of the CGuardTM Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced the appointment of accomplished medical technology executive Scott R. Ward to its Board of Directors. Mr. Ward most recently served as Chief Executive Officer and President of Cardiovascular Systems, Inc. prior to its acquisition by Abbott ABT in April 2023. Paul Stuka, Chairman of the Board of InspireMD, stated, "We are extremely fortunate to add Scott to what I consider to be a world-class Board of Directors. With his extensive operational experience and track record in the cardiovascular space, his insights will be invaluable as the Company rapidly approaches potential U.S. approval of CGuard Prime, the most significant value inflection point in its history. I look forward to Scott's contributions and believe he will have an immediate impact." Marvin Slosman, Chief Executive Officer of InspireMD and Board member, commented, "The addition of Scott to our Board adds tremendous experience in the cardiovascular field, with a track record of growth and innovation as an executive, a board member and investor. His experience and legacy in the space will help guide us through our next stages of advancing our novel carotid platform as part of a comprehensive approach to catalyzing on the market shift toward a stent first standard while also guiding our pipeline of innovation, including our CAS, TCAR and Neuro focus." "I am very excited to join the InspireMD Board at such a transformational time for the company," added Mr. Ward. "With an impressive body of data demonstrating the superior short- and long-term patient outcomes of its novel CGuard Prime carotid stent system, I believe that CGuard, when approved in the U.S., will quickly become a new standard-of-care for carotid intervention and stroke prevention. I look forward to working with my fellow Board members and the InspireMD leadership team to achieve this goal." Mr. Ward has over 40 years of experience in the healthcare industry, including nearly 30 years at Medtronic, Inc. where he served in various leadership roles including as Senior Vice President and President of the CardioVascular, Neurological and Diabetes businesses. Mr. Ward is the Founder of Raymond Holdings, a firm with activities in venture capital, strategy and transactional advisory services for medical technology and life science companies. He earned his Bachelor of Science in Genetics and Cell Biology, his Master of Science in Toxicology, and his Master of Business Administration, all from the University of Minnesota. About InspireMD, Inc. InspireMD seeks to utilize its proprietary MicroNet ® technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD's common stock is quoted on the Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com . Forward-looking Statements This press release contains "forward-looking statements." Forward-looking statements include, but are not limited to, statements regarding InspireMD or its management team's expectations, hopes, beliefs, intentions or strategies regarding the future. Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential", "scheduled" or similar words. Forward-looking statements include, but are not limited to, statements regarding InspireMD or its management team's or directors' expectations, hopes, beliefs, intentions or strategies regarding future events, future financial performance, strategies, expectations, competitive environment and regulation, including potential U.S. commercial launch.. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the company's control, and cannot be predicted or quantified and consequently; actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with our history of recurring losses and negative cash flows from operating activities, significant future commitments and the uncertainty regarding the adequacy of our liquidity to pursue our complete business objectives, and substantial doubt regarding our ability to continue as a going concern; our need to raise additional capital to meet our business requirements in the future and such capital raising may be costly or difficult to obtain and could dilute our stockholders' ownership interests; market acceptance of our products; an inability to secure and maintain regulatory approvals for the sale of our products; negative clinical trial results or lengthy product delays in key markets; our ability to maintain compliance with the Nasdaq listing standards; our ability to generate revenues from our products and obtain and maintain regulatory approvals for our products; our ability to adequately protect our intellectual property; our dependence on a single manufacturing facility and our ability to comply with stringent manufacturing quality standards and to increase production as necessary; the risk that the data collected from our current and planned clinical trials may not be sufficient to demonstrate that our technology is an attractive alternative to other procedures and products; intense competition in our industry, with competitors having substantially greater financial, technological, research and development, regulatory and clinical, manufacturing, marketing and sales, distribution and personnel resources than we do; entry of new competitors and products and potential technological obsolescence of our products; inability to carry out research, development and commercialization plans; loss of a key customer or supplier; technical problems with our research and products and potential product liability claims; product malfunctions; price increases for supplies and components; insufficient or inadequate reimbursement by governmental and other third-party payers for our products; our efforts to successfully obtain and maintain intellectual property protection covering our products, which may not be successful; adverse federal, state and local government regulation, in the United States, Europe or Israel and other foreign jurisdictions; the fact that we conduct business in multiple foreign jurisdictions, exposing us to foreign currency exchange rate fluctuations, logistical and communications challenges, burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction; the escalation of hostilities in Israel, which could impair our ability to manufacture our products; and current or future unfavorable economic and market conditions and adverse developments with respect to financial institutions and associated liquidity risk. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov . The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise. Investor Contacts: Craig Shore Chief Financial Officer InspireMD, Inc. 888-776-6804 craigs@inspiremd.com Chuck Padala, Managing Director LifeSci Advisors 646-627-8390 chuck@lifesciadvisors.com investor-relations@inspiremd.com © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Whether you’re new to AI or a tech-savvy professional, it’s clear that artificial intelligence can significantly enhance productivity and reduce mental effort. Much like learning to ride a bicycle, drive a car, or use a smartphone to save time, AI can now streamline your workday, allowing you to focus on the tasks that truly matter. Here’s how to incorporate common AI tools like ChatGPT, Bing Chat, Gemini, and others into your role for maximum impact. AI can act as your personal assistant, handling repetitive tasks and improving communication efficiency. Tools like Google’s Smart Compose and Microsoft Outlook can suggest quick draft replies, flag critical emails, and automate follow-ups. This not only saves you time but also helps prioritize important messages so you can respond faster. Need help crafting the perfect response? Whether you’re dealing with an angry client or a difficult colleague, AI chatbots like ChatGPT can suggest a more diplomatic tone, improve your wording, and help you navigate tricky conversations. Additionally, AI-powered scheduling tools like Calendly or Google Calendar take the hassle out of arranging meetings by automatically syncing with your availability. If you’re constantly hunting for files, let Google Drive’s AI search or Microsoft SharePoint do the heavy lifting. These tools allow you to quickly locate important documents and folders, reducing time spent searching. You can also use meeting transcription tools like Otter or Fireflies.ai to capture important points during discussions and generate summaries without having to manually take notes. AI isn’t just about saving time—it can also help you make smarter, more informed decisions by acting as your personal data scientist. Sales and marketing professionals can use AI-driven tools like Hubspot and Salesforce Einstein to analyze customer data, predict trends, and focus on the most promising leads. In fields like research or healthcare , tools like IBM Watson can quickly sift through vast amounts of data and present critical insights in an easily digestible format. Whether it’s analyzing patient data, student performance, or customer behavior, AI enables you to make data-driven decisions with ease and efficiency. For creatives or those involved in content creation, AI can be a game-changer. AI chatbots and tools like Grammarly can improve your writing by fixing grammar, enhancing readability, and generating new ideas. Once your report, presentation, or proposal is drafted, use AI to give it a professional finish in no time. If you’re a designer , AI-powered platforms like Canva and Adobe Spark offer ready-made templates, design suggestions, and color palettes to help you create visually stunning marketing materials, social media posts, and presentations with minimal effort. These tools allow you to create professional-quality content without a steep learning curve. For content writers, AI chatbots like Jasper provide inspiration, generate product descriptions, and even craft blog posts or social media copy, saving you time while delivering high-quality output. AI can help streamline the content creation process, letting you focus on creative strategy rather than the labor-intensive tasks. AI isn’t just a tool for specific tasks—it can help you maximize productivity across all areas of your work. Whether you’re managing emails, scheduling meetings, analyzing data, or creating content, AI is designed to save you time and reduce mental fatigue. By integrating these powerful AI tools into your daily workflow, you can free up time to focus on high-value tasks that require your unique expertise.
Can Ozempic make America slim again? RFK Jr and Musk are at oddsSimon Harris has spoken to the Dublin woman who won a civil case against mixed martial arts fighter Conor McGregor to praise her courage. The Taoiseach said he also wanted to tell Nikita Hand, a hair colourist from Drimnagh, that her case had prompted an increase in women coming forward to ask for support. Ms Hand, who accused the sportsman of raping her in a Dublin hotel in December 2018, won her claim against him for damages in a civil case at the High Court on Friday. The total amount of damages awarded to Ms Hand by the jury was €248,603.60. Mr McGregor said in a post on social media on Friday that he intends to appeal against the decision. That post has since been deleted. Speaking to the media on Saturday, Mr Harris said he told Ms Hand of the support she has from people across Ireland. He said: "I spoke with Nikita today and I wanted to thank her for her incredible bravery and her courage. “I wanted to make sure that she knew how much solidarity and support there was across this country for her bravery. I also wanted to make sure she knew of what the Dublin Rape Crisis Centre had said yesterday – that so many other women have now come forward in relation to their own experiences of sexual abuse as a result of Nikita’s bravery.” The Dublin Rape Crisis Centre said the case has had a “profound effect” on the people the charity supports, and that over the first 10 days of the High Court case, calls to its national helpline increased by almost 20%. It said that first-time callers increased by 50% compared to the same period last year, and were largely from people who had experienced sexual violence who were distressed and anxious from the details of case and the views people had to it. Mr Harris said: “I wanted to speak with her and I wanted to wish her and her daughter, Freya, all the very best night, and I was very grateful to talk with Nikita today. Her bravery, her courage, her voice has made a real difference in a country in which we must continue to work to get to zero tolerance when it comes to domestic, sexual and gender-based violence. I don’t want to say too much more, because conscious there could be further legal processes, but I absolutely want to commend Nikita for her bravery, for her courage, for using her voice.” Justice Minister Helen McEntee praised Ms Hand’s bravery and said she had shown “there is light at the end of the tunnel”. She said: “I just want to commend Nikita for her bravery, for her determination and the leadership that she has shown in what has been – I’ve no doubt – a very, very difficult time for her and indeed, for her family." She added: “Because of wonderful people like Nikita, I hope that it shows that there is light at the end of the tunnel, that there are supports available to people, and that there is justice at the end of the day.” Ms Hand said in a statement outside court on Friday that she hoped her case would remind victims of assault to keep “pushing forward for justice”. Describing the past six years as “a nightmare”, she said: “I want to show (my daughter) Freya and every other girl and boy that you can stand up for yourself if something happens to you, no matter who the person is, and justice will be served.” During the case, Ms Hand said she was “disappointed and upset” when the Director of Public Prosecutions (DPP) decided not to prosecute the case after she made a complaint to the Irish police. In a letter to her in August 2020, the DPP said there was “insufficient evidence” and there was not a reasonable prospect of conviction. Ms Hand asked the DPP to review the decision, saying she felt she was being treated differently because one of the suspects was famous. Asked about the DPP’s decision not to prosecute, Mr Harris and Ms McEntee stressed the importance of the DPP’s independence on whether to prosecute. “There are obviously structures in place where the DPP can meet a victim and can outline to them their reasons for not taking the case,” Mr Harris said. “But there’s also always an opportunity for the DPP in any situation – and I speak broadly in relation to this – to review a decision, to consider any new information that may come to light, and I don’t want to say anything that may ever cut across the ongoing work of the DPP.” Ms McEntee stressed that there should “never be any political interference” in the independence of the DPP’s decisions. She said: “I have, since becoming minister, given priority to and enabled a new office within the DPP to open specifically focused on sexual offences, so that this issue can be given the focus and the priority that it needs." For all the latest news from Dublin and surrounding areas visit our homepage . Join our Dublin Live breaking news service on WhatsApp. Click this link to receive your daily dose of Dublin Live content. We also treat our community members to special offers, promotions, and adverts from us and our partners. If you don’t like our community, you can check out any time you like. If you’re curious, you can read our Privacy Notice .Meetion Introduces DirectorC2 Ergonomic Keyboard and Mouse Combo for Comfort and Efficiency
Qatar tribune As the Ukraine war, launched by the imperialist invasion by Russian despot Vladimir Putin, passed its 1,000-day mark this month, President Volodymyr Zelenskyy’s troops are newly empowered by the Biden administration to use long-range ATACMS missiles to attack targets in Russia, which they did. And Moscow responded by launching its own new mid-range ballistic missile. Biden is also sending antipersonnel mines to Ukraine, marking a couple significant shifts in strategy in his waning weeks at the helm. What everyone knows is that this late flurry of aid for Kyiv’s defenses may soon change. Donald Trump, with his dangerous America First isolationism, wants out of foreign wars and could leave Ukraine to be mauled and consumed by the Russian bear. He’s said that he intends to end the war “in one day,” which seems to include the idea of significant and unacceptable concessions to Russia and Putin, a strongman whose style Trump has often seemed to admire. Of course, this terrible war should not be prolonged. Even Zelenskyy expressed some optimism that Trump might be able to help end the war sooner, to some extent due to his existing credibility in the Kremlin. There’s a world here where the clarity of Trump’s non-commitment to both Ukraine and the global Western security apparatus and alliances like NATO at least pushes European allies to step up and help broker an end to the conflict that does not constitute a Russian victory. This, however, is only possible if Russia comes to feel that this victory is not possible, or at least comes at too extravagant a cost. That means that Ukraine needs to continue to have the tools not just to defend itself but to strike back, as it has begun doing with the long-range missiles. For its part, Russia has suffered estimated military casualties, including killed and wounded, in excess of 700,000, destroyed its military readiness, is in the midst of uncontrolled inflation and seems destined to at best have an incredibly Pyrrhic victory. Now, it will suffer heavier casualties and infrastructural damage on its own soil from Ukraine’s latest weapons. This doesn’t mean that Ukraine has the upper hand, per se, but it does mean that this is a grinding stalemate that no one really wants to continue. Russia has been increasingly desperate for an edge, now allowing thousands of North Korean troops to join the fray, committed to saving face to protect the aspirations and public image of its despotic leader. But the tides can turn quickly if Ukraine’s means to defend itself begin drying up. So let the Biden administration shore that up for now, and we hope that Trump’s lean towards a Russia-favoring resolution is tempered in the months until he takes office. History and common sense point to a series of escalating consequences if an aggressive and expansionist Russia is allowed to win this war outright in the ways it had initially set out to do — seizing large swaths of territory and rewiring the social and political fabric of the land. Putin will not be appeased, or satisfied with this meal at Ukraine’s expense. He’ll always want more, which is why he must be stopped. Copy 24/11/2024 10
Meetion Introduces DirectorC2 Ergonomic Keyboard and Mouse Combo for Comfort and Efficiency 11-26-2024 07:00 PM CET | Business, Economy, Finances, Banking & Insurance Press release from: ABNewswire Meetion launches the DirectorC2 ergonomic keyboard and mouse combo, combining comfort, multi-device support, and advanced features for diverse users. Meetion [ https://www.meetion.com/ ], a global leader in gaming and ergonomic peripherals, has announced the launch of its innovative Dual-Mode Ergonomic Keyboard and Mouse Combo DirectorC2, set to revolutionize productivity and comfort for users across industries. Designed with meticulous attention to ergonomics and advanced technology, this groundbreaking product caters to a diverse audience, from office professionals to gamers, with an emphasis on health and efficiency. Image: https://www.abnewswire.com/uploads/b4d57c20f7d08e362698dec97418bad2.jpg The DirectorC2 represents a leap forward in ergonomic design. Its split keyboard and vertical mouse are engineered to reduce wrist pressure and maintain a natural hand posture, combating the discomfort often associated with prolonged computer use. Adding to its comfort factor, the device features a soft synthetic leather palm rest layered with memory foam, ensuring support for extended periods of work or gaming. The combo's dual connectivity - 2.4G wireless and dual Bluetooth 5.3 - delivers unmatched flexibility. It seamlessly connects with Mac, iOS, Windows, and Android systems, making it ideal for multi-device users. With a rechargeable 500mAh lithium battery and convenient Type-C charging, the DirectorC2 ensures reliability and reduced downtime, a crucial feature for professionals and gamers alike. Image: https://www.abnewswire.com/uploads/1996491b7407a7e96b1e898ee80b9050.jpg Meetion's focus on user experience is evident in the product's customizable features. The keyboard boasts 112 keys (or 113, depending on configuration) and weighs 930 grams, while the mouse includes five functional keys, a vertical design for enhanced ergonomics, and a four-level adjustable DPI (800, 1200, 1600, 2400), allowing users to adapt to various scenarios effortlessly. Whether for precision-intensive design tasks or fast-paced gaming sessions, the DirectorC2 promises a smooth and responsive experience. The company has identified a wide target market for the product. Office workers, freelancers, and corporate professionals will benefit from its productivity-enhancing capabilities. Students and educators can take advantage of its ergonomic features during extended study sessions. Gamers seeking high sensitivity and comfort will find it indispensable, while health-conscious consumers can use it to alleviate posture-related ailments such as "office syndrome." Customer feedback has underscored the DirectorC2's excellence. Users report significant reductions in hand and wrist fatigue, praising its multi-device compatibility, long battery life, and sleek design. The keyboard and mouse combo not only enhances productivity but also transforms workspaces into more comfortable and efficient environments. Aaron, the spokesperson for Meetion, emphasized the company's commitment to delivering cutting-edge products that marry functionality with innovation. "The DirectorC2 is more than just a keyboard and mouse combo; it's a tool designed to elevate the user experience across all domains. Whether you're a student, gamer, or office professional, this product will redefine the way you work and play," he said. Image: https://www.abnewswire.com/uploads/285de7f9b5dad8f4d4333084f89e4596.jpg Meetion's journey from a Shenzhen startup in 2013 to a global player in over 50 countries is a testament to its dedication to quality and performance. With a product portfolio spanning over 158 peripherals, the company continues to push the boundaries of ergonomic and gaming technology. Learn more at: https://www.meetion.com/ For more details, contact Meetion at info@meetion.com or call +86 75523579736 About Company: Meetion is a global leader in ergonomic and gaming peripherals, offering high-quality products designed for performance and user comfort. Established in 2013, the company serves customers in over 50 countries with a diverse range of cutting-edge solutions. Media Contact Company Name: Meetion Contact Person: Aaron Lee Email:Send Email [ https://www.abnewswire.com/email_contact_us.php?pr=meetion-introduces-directorc2-ergonomic-keyboard-and-mouse-combo-for-comfort-and-efficiency ] City: Shenzhen Country: China Website: http://meetion.com This release was published on openPR.